The question of whether screening colonoscopies continue providing value in adults over 75 has significant implications for healthcare resource allocation and individual medical decisions. While guidelines typically recommend stopping routine screening at this age, many older adults continue receiving colonoscopies based on prior findings. New evidence from JAMA Network examines whether previous adenoma detection meaningfully stratifies cancer risk in this population. The retrospective cohort study analyzed adults 75 years and older, comparing cumulative colorectal cancer incidence and all-cause mortality between those with and without adenomas detected on prior colonoscopy examinations. The research tracked long-term outcomes to determine if adenoma history serves as a reliable predictor of future malignancy in this age group. This analysis addresses a critical gap in geriatric oncology guidance. Most colonoscopy screening studies focus on younger populations where life expectancy clearly justifies intervention. For adults over 75, the calculus becomes more complex as competing mortality risks increase and remaining lifespan decreases. The study's findings could inform more nuanced screening recommendations that account for individual adenoma history rather than applying blanket age cutoffs. If adenoma detection proves predictive of cancer risk even in older adults, it might justify continued surveillance in select patients. Conversely, if the association weakens with age, resources might be better directed elsewhere. The research methodology using real-world retrospective data provides practical insights for clinical decision-making, though observational studies cannot establish causation and may reflect selection bias in who receives follow-up colonoscopies at advanced ages.